VI4 Home

Our Mission: To train the next generation of scientists and physicians and make fundamental discoveries in the areas of infection biology, immunology, and inflammation with the goal of increasing knowledge and improving human health.

Fredrick Haywood, Jr., MBA

Fredrick
Haywood
,Jr., MBA
Social Media and Communications Project Manager
Pathology, Microbiology and Immunology, Molecular Pathogenesis

Fredrick Haywood is the Social Media and Communications Project Manager for the Vanderbilt Institute for Infection, Immunology & Inflammation (VI4) and the Department of Pathology, Microbiology, and Immunology. In this role, he manages The Studio and the VI4/PMI social media accounts, focusing on content creation, email marketing, graphic design, website maintenance and mentoring the VI4 Science Communication Internship.

Phone
615-875-1602
Office Address
MCN C3314A
1161 21st Ave South
Nashville
Tennessee
37232
fredrick.haywood@vumc.org

Recommended Reading - November & December 2024

1. Framework for exploring the sensory repertoire of the human gut microbiota. Ross P, et al. in mBio, May 17, 20242. Universal paramyxovirus vaccine design by stabilizing regions involved in structural transformation of the fusion protein. Langedijk J, et al. in Nature, May 31, 2024

Douglas Mitchell, PhD

Douglas
Mitchell
,PhD
William Kelly Warren Sr. Chair in Biochemistry
Professor of Chemistry, Director of Vanderbilt Institute for Chemical Biology

Our lab focuses on the discovery, biosynthesis, and re-engineering of ribosomally synthesized and post-translationally modified peptides (RiPPs). Using a genes-to-molecules approach, we leverage big data genomics analyses to inform RiPP structure and function. These efforts routinely uncover unique enzyme chemistries that constrain peptides in a manner that enables high-affinity engagement with biological targets. Our work aims to harness RiPP biosynthetic pathways to create new-to-nature compounds with novel activities to improve human health.

 

Keywords: chemical biology, genome mining, bioinformatics, microbial natural products, enzyme chemistry, antibiotics, drug design

Robbie Watson, Ph.D., M.P.H.

Robbie
Watson
, Ph.D., M.P.H.
Associate Professor
Medicine, Division of Adult Infectious Disease

Lab Research: The Watson lab is focused on the notorious human pathogen, Mycobacterium tuberculosis, which remains a major global health threat.  M. tuberculosis has evolved a variety of specific adaptations to not only survive but also replicate within the harsh environment inside a macrophage. We want to understand how host macrophages sense and respond to M. tuberculosis and how specific host proteins regulate the outcome of M. tuberculosis infection, both inside macrophages ex vivo and in a mouse model of infection. We have recently started to focus on the interface between mitochondria and M. tuberculosis. Specifically, we are interested in uncovering the molecular mechanisms that explain why mutations in several genes related to mitochondrial function confer susceptibility to M. tuberculosis in humans.

 

Keywords: Innate immunity, macrophage, mitochondria, immunometabolism, autophagy type I inteferon, gene expression, Mycobacterium tuberculosis, intracellular bacterial pathogens

Paul Blair, MD MHS

Paul
Blair
,MD MHS
Assistant Professor
Division of Infectious Diseases

Dr. Blair’s objective is to identify effective and scalable solutions to rapidly diagnose and appropriately treat severe and emerging infectious diseases in hospitalized and remote settings. With experience working with Department of Defense and international partners, he has described scrub typhus in Uganda, the clinical course and treatment of severe viral illnesses, and point-of-care ultrasound performance in diverse settings. His overall research goal is to address the striking need for tools to facilitate early patient triage and targeted treatments in low-resource and outbreak settings with current projects in the U.S., Uganda, and Peru. His publication history is listed here https://www.ncbi.nlm.nih.gov/myncbi/paul.blair.1/bibliography/public/

 

Keywords: Communicable Diseases, Emerging; Disease Outbreaks; Diagnostic Techniques and Procedures;Ultrasonography, Interventional

Kristin Patrick, PhD

Kristin
Patrick
, PhD
Associate Professor
Pathology, Microbiology and Immunology, Molecular Pathogenesis
kristin.patrick@vumc.org

My lab works to elucidate the molecular mechanisms of innate immune regulation in macrophages. While a rapid and robust innate immune response is needed to limit infection, a response that is too strong carries risks like cytokine storm. Therefore, macrophage gene expression needs to be tightly regulated. My lab works to implicate post-transcriptional regulatory mechanisms (e.g., pre-mRNA splicing, mRNA export, RNA decay/turnover, RNA localization etc.) in shaping inflammatory gene expression. We employ a multidisciplinary toolbox of protein and RNA biochemistry, transcriptomics, and microscopy-based approaches to tease apart pathways of interest in mechanistic detail. By highlighting new and unexpected ways that RBPs balance innate immune responses, our work furthers our understanding of how inflammation can be dysregulated during infection and in a variety of human diseases.

 

Keywords: Innate immunity, macrophage, gene expression, splicing, chromatin, transcription, Mycobacterium tuberculosis, intracellular bacterial pathogens.

Nicole Kirchoff, PhD

Nicole
Kirchoff
PhD

Dr. Nicole Kirchoff received her PhD in Microbiology at Oregon State University. Dr. Kirchoff is a microbial ecologist who has studied how the gut microbiome is related to the health and fitness of the vertebrate host. She has characterized the gut microbiome of many vertebrates including fish, dogs, mice, and humans. While she does have microbiome wet lab experience, she primarily uses bioinformatics and nonparametric statistics to compare gut microbial composition across samples. She has experience in taxonomic and functional annotation of the gut microbiome. Her most recent work compared bacterial taxonomy and antimicrobial resistance gene profiles between healthy patients and patients with C. difficile infection.

Dr. Nicole Kirchoff will provide support to the VMIC community on microbiome study design & microbiome data analysis. She is currently hosting office hours Tuesdays and Thursdays from 10am to noon to answer any microbiome related questions. Here you can discuss hypotheses, study design, analysis, feasibility, etc. of your microbiome studies. You must schedule an appointment ahead of time to meet with Dr. Kirchoff using this link: https://outlook.office365.com/owa/calendar/MicrobiomeOfficeHours@vumc.org/bookings/

Do you have a Microbiome project, but you don’t know where to start with analyzing your data? Stay tuned for upcoming opportunities to have Dr. Kirchoff’s support for microbiome data analysis (e.g., 16S rRNA sequencing, metagenomics, metatranscriptomics) for projects from the VU and VUMC community!

nicole.kirchoff@vumc.org

Anthony R. Flores, MD, MPH, PhD, FPIDS

Anthony
R.
Flores
MD, MPH, PhD, FPIDS
Director, Pediatric Infectious Diseases
Professor, Department of Pediatrics
Medical Center North
1161 21st Avenue South
Room / Suite
D-7235
Nashville
Tennessee
37232

Dr. Flores is a physician-scientist with expertise in pediatric infectious diseases and Professor of Pediatrics at Vanderbilt University Medical Center. Dr. Flores’ research focuses on the bacterial genomic epidemiology and virulence mechanisms of pathogenic streptococci (group A and B streptococci) and is funded by grant awards from the NIH/NIAID. His research uses a combination of bacterial disease epidemiology, cutting-edge genomic technologies, and classical bacteriology techniques to understand epidemic clonal emergence and mechanisms of disease in streptococci. His work also includes examining the mechanisms of group A streptococcal carriage as a risk factor for disease in children.

Bacterial Infections, Strep Throat, Pediatric Infectious Disease